news
FDA approves AUDENZ™, an adjuvanted Influenza A pandemic vaccine
The US FDA has approved AUDENZ, a vaccine formulated with MF59® adjuvant, as an Influenza A H5N1 vaccine that can be quickly deployed in the event of a pandemic.
List view / Grid view
Viruses
Filter the results
news
Johnson & Johnson launch response to Coronavirus
Johnson & Johnson announced Janssen Pharmaceutical Companies will work collaboratively to screen for antiviral therapies and vaccine therapies against 2019-nCoV.
news
CEPI announces three programmes to develop coronavirus vaccine
The CEPI has announced three respective projects with Inovio, the University of Queensland and Moderna, to develop a vaccine for the novel coronavirus, nCoV-2019.
news
Effectiveness of HPV vaccines Cervarix and Gardasil under question
Analysis of the designs of Phase II and III efficacy trials for HPV vaccines suggest they overstated their effectiveness against cervical cancer, according to researchers.
news
Nanoparticle gene therapy drug delivery for paediatric brain cancer tested in mice
A study has shown that PBAE nanoparticles could replace viral vectors in gene therapies and provide a safe treatment option for paediatric brain cancer patients.
news
Report indicates seasonal influenza vaccine market in Asia will reach $1bn by 2028
A new report indicates that drug launches and new formulations will drive the growth of the seasonal influenza vaccine market in China, India and Japan from $914m in 2018 to $1.05bn in 2028.
news
New breakthrough can effectively deliver medications into the brain
Scientists have found a way to effectively transport medication into the brain which could lead to improved treatments for neurological and neurodegenerative diseases.
news
Antiviral drug not beneficial for reducing mother-to-child transmission of hepatitis B
Tenofovir disoproxil fumarate (TDF) does not significantly reduce mother-to-child transmission of hepatitis B virus when taken during pregnancy and after delivery.
news
Gene-based Zika vaccine is safe and immunogenic in healthy adults
Results from two Phase 1 clinical trials show an experimental Zika vaccine is safe and induces an immune response in healthy adults.
news
Virus-like particle vaccine protects against RSV vaccine-enhanced respiratory disease
Researchers have discovered that a virus-like particle vaccine can prime the body's immune response and prevent the severe respiratory diseases...
news
New vaccine offers hope for pneumonia
Scientists are developing a vaccine by targeting strains of S. pneumoniae...
news
Flu vaccine found to be ineffective in leukaemia patients
Leukaemia patients who were vaccinated against influenza were just as likely as their unvaccinated peers to develop flu, suggesting that additional steps are necessary to protect high-risk individuals...
news
Vaccine demonstrates significant efficacy against severe rotavirus
Results from a Phase 3 efficacy study in India of the rotavirus vaccine Rotasil showed the vaccine to be safe, against severe rotavirus gastroenteritis...
news
Poliovirus therapy induces immune responses against cancer
Investigational therapy directly kills tumour cells and unmasks them to the body's defences.
news
Zika virus shown to kill brain cancer stem cells
Research published in The Journal of Experimental Medicine suggests potential treatment for glioblastoma